Kanyr Pharma Inc.

Canada

Commandez votre montre hebdomadaire Kanyr Pharma Inc.
Quantité totale PI 4
Rang # Quantité totale PI 392 052
Note d'activité PI 1,3/5.0    4
Rang # Activité PI 242 698

Brevets

Marques

1 0
1 0
2 0
0
 
Dernier brevet 2025 - Phosphatase inhibitors as nk cel...
Premier brevet 2022 - Phosphatase inhibitors as nk cel...

Derniers inventions, produits et services

2023 Invention Combined inhibition of tyrosine phosphatases tcptp and ptp1b and pd-1 blockage immunotherapy in t...
2022 Invention Phosphatase inhibitors as nk cells modulators for the treatment of cancer. The present document ...
Invention Phosphatase inhibitors as nk cells modulators for the treatment of cancer. The present document d...